Home  >  Products  >  STXBP4 (syntaxin binding protein 4 ) Blocking Peptide (the N terminal of STXBP4)(100ug)
STXBP4 (syntaxin binding protein 4 ) Blocking Peptide (the N terminal of STXBP4)(100ug)

STXBP4 (syntaxin binding protein 4 ) Blocking Peptide (the N terminal of STXBP4)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-STXBP4 Antibody (ARP65839_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP65839
Size: 100ug
Weight: 62kDa
Gene: 252983
Format: Lyophilized powder
Target: STXBP4 plays a role in the translocation of transport vesicles from the cytoplasm to the plasma membrane. STXBP4 inhibits the translocation of SLC2A4 from intracellular vesicles to the plasma membrane by STX4A binding and preventing the interaction between STX4A and VAMP2. Stimulation with insulin disrupts the interaction with STX4A, leading to increased levels of SLC2A4 at the plasma membrane. STXBP4 may also play a role in the regulation of insulin release by pancreatic beta cells after stimulation by glucose.
Alternative names: FLJ16496; MGC149829; MGC50337; Synip
See Full Product Listings >